---
title: "Hyphens Pharma completes second tranche of Ardence Pharma acquisition"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/239747194.md"
description: "Hyphens Pharma acquired an additional 17% stake.Hyphens Pharma International completed the second tranche of acquiring 17% of shares in Ardence Pharma on 9 May.The total consideration for the Tranche 2 Sale Shares, subject at the exchange rate of $1.00: RM3.25 was equivalent to $3.35m (RM10.9m).Following the transaction, Hyphens Pharma now holds an 82% stake in Ardence Pharma.The company will make further announcements as and when there are material developments on the proposed acquisition in due course."
datetime: "2025-05-12T03:01:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239747194.md)
  - [en](https://longbridge.com/en/news/239747194.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239747194.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/239747194.md) | [English](https://longbridge.com/en/news/239747194.md)


# Hyphens Pharma completes second tranche of Ardence Pharma acquisition

**Hyphens Pharma acquired an additional 17% stake.**

Hyphens Pharma International completed the second tranche of acquiring 17% of shares in Ardence Pharma on 9 May.

The total consideration for the Tranche 2 Sale Shares, subject at the exchange rate of $1.00: RM3.25 was equivalent to $3.35m (RM10.9m).

Following the transaction, Hyphens Pharma now holds an 82% stake in Ardence Pharma.

The company will make further announcements as and when there are material developments on the proposed acquisition in due course.

### 相關股票

- [Hyphens Pharma (1J5.SG)](https://longbridge.com/zh-HK/quote/1J5.SG.md)

## 相關資訊與研究

- [Hyphens Pharma profit dives 44% in 2025 despite record 40.7% gross margins](https://longbridge.com/zh-HK/news/276821357.md)
- [IFW Dresden selects Agnitron Agilis 100 MOCVD platform for precursor chemistry and ultra-wide-bandgap materials development](https://longbridge.com/zh-HK/news/279074236.md)
- [ZAWYA-PROJECTS: Dubai's DP World sets 2026 capex budget at $3bn](https://longbridge.com/zh-HK/news/279073080.md)
- [Santander Discloses Senior Executive’s Sale of ADRs on NYSE](https://longbridge.com/zh-HK/news/279073285.md)
- [Dr. Reddy’s Flags Phase III Setback as Immutep Halts Key Lung Cancer Trial](https://longbridge.com/zh-HK/news/279076056.md)